Compare Cassava Sciences Inc (FLNA) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Prudential Financial Inc — how do they compare? Cassava Sciences Inc trades at $0.82 (market cap $39.40M), while Prudential Financial Inc trades at $111.8 (market cap $39.17B). The key difference: Prudential Financial Inc is far larger — about 994.2× Cassava Sciences Inc's market cap, and Prudential Financial Inc pays a 4.93% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and Prudential Financial Inc for 145 Days on average.
| FLNA | PRU | |
|---|---|---|
Market Cap | $39.40M | $39.17B |
Volume | 759,018 | 1,436,917 |
Sector | Health | Financials |
52-Week High | $4.64 | $125.13 |
52-Week Low | $0.68 | $92.00 |
Typical Hold Time | 37 Days | 145 Days |
Enterprise Value | -$43.28M | $67.95B |
Dividend Yield | — | 4.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.8157, down 6.77% today, with a bearish technical signal from moving averages. The company shows improving quarterly EPS trends, beating expectations in recent quarters, though it remains unprofitable with negative ROE and ROA. Recent FDA clearance for its epilepsy drug trial provides a positive catalyst. Analyst sentiment is bullish with 67% buy ratings.
The outlook hinges on clinical progress; upside exists if Phase 2a trials succeed, but high cash burn and lack of revenue pose significant risks. Investors should weigh the strong analyst support against the company's financial challenges and binary clinical outcomes.
Prudential Financial (PRU) trades at $112.36, down 1.04% with a bearish technical outlook. The stock shows attractive valuation metrics including a P/E of 10.19 and P/S of 0.61, while recent earnings beat expectations in two of the last three quarters. The company is executing a strategic overhaul including a $3 billion capital rotation plan and emerging market exits, while benefiting from higher interest rates that boost investment income.
PRU presents a value opportunity with strong fundamentals but faces near-term technical pressure. The 67.57% analyst hold rating reflects cautious optimism, with the current price above the $105.67 consensus target. Key risks include execution of strategic initiatives and annuity market competition, while higher rates provide tailwinds for insurance operations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
